Table 1.
Baseline characteristics of participants.
| Characteristics | Dyn (n = 30) | Iso (n = 30) | p |
|---|---|---|---|
| Gender | |||
| Male/female, n (%) | 11 (37%)/19 (63%) | 18 (60%)/12 (40%) | 0.325 |
| Age (year) | 65.9 (2.9) | 65.0 (3.1) | 0.233 |
| Body height (cm) | 159.16 (9.75) | 157.29 (7.30) | 0.404 |
| Body weight (kg) | 67.65(12.02) | 69.68(13.53) | 0.542 |
| Body mass index (kg/m2) | 26.68 (4.17) | 28.11 (4.93) | 0.231 |
| Duration of T2DM (year) | 9.13 (7.40) | 11.46 (7.77) | 0.239 |
| HbA1c (%) | 7.24 (1.1) | 7.43 (1.2) | 0.522 |
| Kellgren–Lawrence grade | 1.66 (0.80) | 1.47 (0.82) | 0.343 |
| I, n (%) | 16 (53) | 22 (73) | |
| II, n (%) | 8 (27) | 2 (7) | |
| III, n (%) | 6 (20) | 6 (20) | |
| Taking NSAIDs n (%) | 1 (3.3%) | 1 (3.3%) | 1 |
Dyn = dynamic group, Iso = isometric group. T2DM = Type 2 diabetes mellitus. Values are means with standard deviations (in brackets) unless indicated otherwise. Non-steroidal anti-inflammatory drugs (NSAIDs).